Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-07

FDA Approved: TADALAFIL — Supplemental Application (HEC Pharm USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for tadalafil from HEC Pharm USA Inc., indicating approval of an additional generic tadalafil product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

SUPPL AP for TADALAFIL (TADALAFIL)